Cargando…
DNA N6-Methyladenine (6mA) Modification Regulates Drug Resistance in Triple Negative Breast Cancer
Triple negative breast cancer (TNBC) is a subtype of breast cancer with strong aggressiveness and poor clinical treatment effect, accounting for about 10–20% of breast cancer cases. N(6)-methyldeoxyadenosine (6mA) is the most conservative DNA modification in prokaryotes and eukaryotes. It is widely...
Autores principales: | Sheng, Xianneng, Wang, Jinqiu, Guo, Yu, Zhang, Jiabo, Luo, Jin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7887291/ https://www.ncbi.nlm.nih.gov/pubmed/33614498 http://dx.doi.org/10.3389/fonc.2020.616098 |
Ejemplares similares
-
DNA N(6)-methyladenine modification in hypertension
por: Guo, Ye, et al.
Publicado: (2020) -
6mA-Pred: identifying DNA N6-methyladenine sites based on deep learning
por: Huang, Qianfei, et al.
Publicado: (2021) -
6mA-StackingCV: an improved stacking ensemble model for predicting DNA N6-methyladenine site
por: Huang, Guohua, et al.
Publicado: (2023) -
DNA N6-Methyladenine Modification in Eukaryotic Genome
por: Li, Hao, et al.
Publicado: (2022) -
iDNA6mA-Rice: A Computational Tool for Detecting N6-Methyladenine Sites in Rice
por: Lv, Hao, et al.
Publicado: (2019)